Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year
2024-07-10 13:30
3D Artificial Cornea from Stem Cells: Chula Researchers Advance Canine Corneal Wound Treatment
2024-07-10 09:00
KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells
2024-07-09 23:00
Alteogen Receives Ministry of Food and Drug Safety (MFDS) Approval for Tergase®
2024-07-08 21:00
MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions
2024-07-08 17:14
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors
2024-07-08 16:28
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics
2024-07-08 14:30
Olverembatinib Approved for Commercialization in Macau China
2024-07-08 08:55
XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country
2024-07-05 21:18
Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC)
2024-07-05 21:00
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition
2024-07-05 19:00
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy
2024-07-05 16:30
Innovent and IASO Bio Enhance Strategic Collaboration in Cell Therapy
2024-07-05 16:30
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
2024-07-05 16:07
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia
2024-07-05 15:56
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
2024-07-04 11:17
Ascentage Pharma Received US$100 Million Option Payment from Takeda
2024-07-04 08:28
/C O R R E C T I O N -- Menarini Silicon Biosystems/
2024-07-03 03:24
Bloomage Ranks on World Brand Lab's China 500 Most Valuable Brands List
2024-07-02 21:00
PolyU study reveals the mechanism of bio-inspired control of liquid flow, enlightening breakthroughs in fluid dynamics and nature-inspired materials technologies
2024-07-02 20:25
1
24
25
26
27
28
451